Nephrectomy News and Research

RSS

Temsirolimus effective for mRCC patients on hemodialysis

Research findings published in the International Journal of Clinical Oncology suggest that temsirolimus effectively stabilizes disease progression in patients with metastatic renal cell carcinoma undergoing hemodialysis.

22 Nov 2012

Comparing surgical approaches in nephrectomy patients

The retroperitoneal approach to laparoscopic nephrectomy may provide a suitable alternative to the transperitoneal approach for patients, show findings from a literature review.

8 Nov 2012

Active surveillance of small kidney masses offers similar cancer outcomes to radical or partial surgery

Active surveillance of small kidney masses is a safe and effective alternative to immediate surgery, with similar overall and cancer specific survival rates, according to a study published in the November issue of the urology journal BJUI.

19 Oct 2012

Phase 3 study of INLYTA fails to meet primary endpoint in treatment-naïve patients with RCC

Pfizer Inc. announced today that a Phase 3 study of INLYTA (axitinib) did not meet its primary endpoint of demonstrating statistically significantly longer progression-free survival, versus sorafenib, in treatment-naïve patients with advanced renal cell carcinoma.

18 Oct 2012

NYU Langone completes robotic surgery education sessions

The Robotic Surgery Center at NYU Langone Medical Center recently completed its second year offering monthly robotic surgery education sessions for minimally invasive robotic procedures.

3 Oct 2012

University of Maryland study findings advance navel nephrectomy as standard of care

In the largest study of its kind, living donors who had a kidney removed through a single port in the navel report higher satisfaction in several key categories, compared to donors who underwent traditional multiple-port laparoscopic removal.

13 Sep 2012

Less is definitely more for men who undergo nephrectomy

Researchers have identified a link between complete kidney removal and erectile dysfunction, a manifestation of endothelial dysfunction that often precedes cardiovascular disease.

6 Aug 2012

Researchers identify link between complete kidney removal and erectile dysfunction

Researchers at the University of California, San Diego School of Medicine have identified a link between patients who undergo total nephrectomy - complete kidney removal - and erectile dysfunction.

31 Jul 2012

NYU Langone surgeons perform robotic-assisted partial nephrectomy in New York

A team of urological surgeons from NYU Langone Medical Center performed a robotic-assisted partial nephrectomy in New York and beamed the procedure from New York via high definition satellite to more than 400 participants attending the American Urological Association's (AUA) 2012 Annual Meeting in Atlanta earlier this week.

24 May 2012

Mount Sinai cancer researchers to present several landmark studies at ASCO meeting

Mount Sinai School of Medicine researchers will present several landmark studies, including data on treatment trends in late-stage cancer, a promising multiple myeloma vaccine, and predictive models of soft tissue sarcomas, prostate and bladder cancer, at the 2012 American Society of Clinical Oncology (ASCO) meeting June 1-5, 2012 in Chicago.

19 May 2012

PN kidney cancer surgery not being used for older, sicker and poorer uninsured patients

An increasingly common and safer type of surgery for kidney cancer is not as likely to be used for older, sicker and poorer patients who are uninsured or rely on Medicare or Medicaid for their health care, according to a new study by researchers at Henry Ford Hospital.

16 May 2012

Association between gender and surgical outcomes of kidney removal not well understood

Women do better than men after surgical removal of part or all of a cancerous kidney, with fewer post-operative complications, including dying in the hospital, although they are more likely to receive blood transfusions related to their surgery.

16 May 2012

First study to compare complication rates after RAPN and LPN

Robot-assisted surgery has replaced another minimally invasive operation as the main procedure to treat kidney cancer while sparing part of the diseased organ, and with comparable results, according to a new research study by Henry Ford Hospital urologists.

16 May 2012

FDA approves Novartis’ Afinitor for treatment of renal angiomyolipomas and TSC

Novartis Pharmaceuticals Corporation announced today that the US Food and Drug Administration (FDA) approved Afinitor (everolimus) tablets for the treatment of adult patients with kidney tumors known as renal angiomyolipomas and tuberous sclerosis complex (TSC), who do not require immediate surgery.

27 Apr 2012

Surgery to remove only the tumor preferable to removing entire kidney

Kidney cancer patients who had only their tumor removed had better survival than patients who had their entire kidney removed, according to a new study from researchers at the University of Michigan Comprehensive Cancer Center.

18 Apr 2012

Papillary renal cell carcinoma patients face low tumour re-occurrence and cancer-related death rates

Patients with papillary renal cell carcinoma, the second most common kidney cancer subtype, face a low risk of tumour recurrence and cancer-related death after surgery. Those are the key findings of a multi-centre study of nearly 600 patients published in the April issue of the urology journal BJUI.

29 Mar 2012

Urological cancer experts to examine latest treatment, research findings at 27th Annual EAU Congress

International urological cancer experts will examine the latest treatment and research findings at the 27th Annual EAU Congress in Paris, France on 24-28 February 2012.

25 Jan 2012

Pfizer, SFJ to conduct axitinib Phase 3 trial in renal cell carcinoma

SFJ Pharma Ltd. II announced today that it has entered into a collaborative development agreement with Pfizer Inc. to conduct a Phase 3 clinical trial in Asia of Pfizer's investigational agent axitinib for the adjuvant treatment of patients at high risk of recurrent renal cell carcinoma (RCC) following nephrectomy.

9 Jan 2012

Astellas, AVEO announce results of tivozanib and sorafenib comparison trial on RCC

AVEO Pharmaceuticals, Inc. and Astellas Pharma Inc. today announced that tivozanib demonstrated superiority over sorafenib in the primary endpoint of progression-free survival (PFS) in TIVO-1, a global, randomized Phase 3 clinical trial evaluating the efficacy and safety of investigational drug tivozanib compared to sorafenib in 517 patients with advanced renal cell carcinoma.

3 Jan 2012

PRI now offers latest surgical robotics for patients with kidney tumors

The Porter Robotics Institute (PRI) now offers the latest in advanced surgical robotics available to patients with kidney tumors, allowing surgeons the ability to remove just a portion of the kidney.

21 Dec 2011

Nephrectomy News and Research

Temsirolimus effective for mRCC patients on hemodialysis

Comparing surgical approaches in nephrectomy patients

Active surveillance of small kidney masses offers similar cancer outcomes to radical or partial surgery

Phase 3 study of INLYTA fails to meet primary endpoint in treatment-naïve patients with RCC

NYU Langone completes robotic surgery education sessions

University of Maryland study findings advance navel nephrectomy as standard of care

Less is definitely more for men who undergo nephrectomy

Researchers identify link between complete kidney removal and erectile dysfunction

NYU Langone surgeons perform robotic-assisted partial nephrectomy in New York

Mount Sinai cancer researchers to present several landmark studies at ASCO meeting

PN kidney cancer surgery not being used for older, sicker and poorer uninsured patients

Association between gender and surgical outcomes of kidney removal not well understood

First study to compare complication rates after RAPN and LPN

FDA approves Novartis’ Afinitor for treatment of renal angiomyolipomas and TSC

Surgery to remove only the tumor preferable to removing entire kidney

Papillary renal cell carcinoma patients face low tumour re-occurrence and cancer-related death rates

Urological cancer experts to examine latest treatment, research findings at 27th Annual EAU Congress

Pfizer, SFJ to conduct axitinib Phase 3 trial in renal cell carcinoma

Astellas, AVEO announce results of tivozanib and sorafenib comparison trial on RCC

PRI now offers latest surgical robotics for patients with kidney tumors

Event guide: 4th Extra-Hepatic Lipid-Based Nanoparticles Delivery Summit eBook

Advancing Intracellular Delivery with LumiPore®

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

The role of UV-Vis in biopharma QC

Latest News